Difficulty: Medium
Average Score: 74%
Practice
Almost all of the diseases detected in neonatal screening programs have a very low prevalence; the strategy is to use the initial screening test to separate a highly suspect group from normal and then follow this suspect group aggressively. Of the following, the disease that has low prevalence rendering it not useful for neonatal screening testing is
Correct answer
D
Rationale
The correct answer is D) neuroblastoma. Neuroblastoma is a rare childhood cancer with a very low prevalence, making it not suitable for inclusion in neonatal screening programs due to the low yield of positive cases.
Phenylketonuria (PKU), hypothyroidism, and cystic fibrosis are more commonly included in neonatal screening programs because they have higher prevalence rates compared to neuroblastoma. These conditions benefit from early detection and intervention to prevent serious health consequences.
In an educational context, understanding the rationale behind selecting diseases for neonatal screening is crucial for pediatric emergency nurses. It helps them prioritize care, identify at-risk patients, and provide timely interventions for conditions with higher prevalence rates that can significantly impact a child's health outcomes. This knowledge enhances their ability to deliver evidence-based care and advocate for the well-being of pediatric patients.
Phenylketonuria (PKU), hypothyroidism, and cystic fibrosis are more commonly included in neonatal screening programs because they have higher prevalence rates compared to neuroblastoma. These conditions benefit from early detection and intervention to prevent serious health consequences.
In an educational context, understanding the rationale behind selecting diseases for neonatal screening is crucial for pediatric emergency nurses. It helps them prioritize care, identify at-risk patients, and provide timely interventions for conditions with higher prevalence rates that can significantly impact a child's health outcomes. This knowledge enhances their ability to deliver evidence-based care and advocate for the well-being of pediatric patients.